How to buy Oncolytics Biotech stock
Learn how to easily invest in Oncolytics Biotech stock.
Oncolytics Biotech is a biotechnology business based in the US. Oncolytics Biotech shares (ONCY) are listed on the NASDAQ and all prices are listed in US Dollars. Oncolytics Biotech employs 29 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Oncolytics Biotech stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ONCY. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Oncolytics Biotech stock price (NASDAQ: ONCY)Use our graph to track the performance of ONCY stocks over time.
Oncolytics Biotech shares at a glance
|Latest market close||$2.23|
|52-week range||$1.09 - $3.39|
|50-day moving average||$2.55|
|200-day moving average||$1.83|
|Wall St. target price||$7.34|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.34|
Buy Oncolytics Biotech stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Oncolytics Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Oncolytics Biotech price performance over time
|1 week (2023-09-21)||1.83%|
|1 month (2023-08-28)||4.21%|
|3 months (2023-06-28)||-7.85%|
|6 months (2023-03-28)||84.30%|
|1 year (2022-09-28)||72.87%|
|2 years (2021-09-27)||2.76%|
|3 years (2020-09-28)||31.95%|
|5 years (2018-09-28)||3.86|
Oncolytics Biotech financials
|Gross profit TTM||$0|
|Return on assets TTM||-49.27%|
|Return on equity TTM||-101.26%|
|Market Capitalization||$173 million|
TTM: trailing 12 months
Oncolytics Biotech share dividends
We're not expecting Oncolytics Biotech to pay a dividend over the next 12 months.
Have Oncolytics Biotech's shares ever split?
Oncolytics Biotech's shares were split on a 10:95 basis on 24 May 2018. So if you had owned 95 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Oncolytics Biotech shares – just the quantity. However, indirectly, the new 850% higher share price could have impacted the market appetite for Oncolytics Biotech shares which in turn could have impacted Oncolytics Biotech's share price.
Oncolytics Biotech share price volatility
Over the last 12 months, Oncolytics Biotech's shares have ranged in value from as little as $1.09 up to $3.3942. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oncolytics Biotech's is 1.7488. This would suggest that Oncolytics Biotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Oncolytics Biotech overview
Oncolytics Biotech Inc. , a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and Bavencio, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
Frequently asked questionsWhat percentage of Oncolytics Biotech is owned by insiders or institutions?
Currently 1.325% of Oncolytics Biotech shares are held by insiders and 1.914% by institutions. How many people work for Oncolytics Biotech?
Latest data suggests 29 work at Oncolytics Biotech. When does the fiscal year end for Oncolytics Biotech?
Oncolytics Biotech's fiscal year ends in December. Where is Oncolytics Biotech based?
Oncolytics Biotech's address is: 322 11th Avenue SW, Calgary, AB, Canada, T2R 0C5 What is Oncolytics Biotech's ISIN number?
Oncolytics Biotech's international securities identification number is: CA6823108759 What is Oncolytics Biotech's CUSIP number?
Oncolytics Biotech's Committee on Uniform Securities Identification Procedures number is: 682310875
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
How to buy HHGregg IncIN stock
Steps to owning and managing HGGG, with 24-hour and historical pricing before you buy.
Ask an Expert